Literature DB >> 10994781

Autocrine growth promotion by multiple hematopoietic growth factors in the established renal cell carcinoma line KU-19-20.

M Tachibana1, A Miyakawa, J Nakashima, M Murai, K Nakamura, A Kubo, J Hata.   

Abstract

Increasing evidence suggests that paraneoplastic syndrome may be mediated by tumor-related cytokine release, although the specific factors involved remain to be clearly defined. The cancer cells used in the present study were obtained from a 67-year-old man with metastatic renal cell carcinoma in the subcutaneous space who demonstrated marked leukocytosis (37,800/mm3). The primary tumor of the kidney was pathologically diagnosed as renal cell carcinoma consistent with the sarcomatoid type. On microscopic observation, the cultured cells exhibited an epithelial appearance with vacuole formation in their cytoplasm. Ultrastructural observations revealed relatively marked microvilli and a tight junction. Significant amounts of GM-CSF, G-CSF, IL-6, and IL-8 concentrations in the culture media were identified by an enzyme-linked immunosorbent assay. Reverse transcriptase polymerase chain reaction (RT-PCR) significantly exhibited marker protein m-RNA expression in cancer cells. In addition, GM-CSF receptor and IL-6 receptor mRNA expression was also demonstrated by RT-PCR. The administration of both IL-6 and GM-CSF induced cell-proliferation activities estimated by both [3H]-thymidine and bromodeoxyuridine labeling. Anti-IL-6 antibody and anti-GM-CSF antibody neutralized the enhanced proliferative activities generated by these cytokines. Our findings indicate that the established renal cancer cell line can be demonstrated by both the production of multiple cytokines and by their promotion of autocrine growth. These cells are thus considered to be useful as an effective model for multipotent differentiated renal cell carcinoma, as well as for studying the mechanisms of action of autocrine growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10994781     DOI: 10.1007/s004410000235

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  5 in total

1.  Interleukin-6 is an autocrine growth factor in human prostate cancer.

Authors:  D Giri; M Ozen; M Ittmann
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

2.  An autopsy case of granulocyte-colony-stimulating-factor-producing extrahepatic bile duct carcinoma.

Authors:  Satoru Matsuyama; Tomonori Shimonishi; Hirofumi Yoshimura; Kensaku Higaki; Kenji Nasu; Mariko Toyooka; Shigehisa Aoki; Keiko Watanabe; Hajime Sugihara
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

3.  p38alpha stabilizes interleukin-6 mRNA via multiple AU-rich elements.

Authors:  Wenpu Zhao; Min Liu; Keith L Kirkwood
Journal:  J Biol Chem       Date:  2007-11-27       Impact factor: 5.157

4.  Recombinant Human Granulocyte Colony-Stimulating Factor Promotes Preinvasive and Invasive Estrogen Receptor-Positive Tumor Development in MMTV-erbB2 Mice.

Authors:  Chun Ling Zhao; Guang Ping Zhang; Zheng Zheng Xiao; Zhi Kun Ma; Cai Peng Lei; Shi Yuan Song; Ying Ying Feng; Ya Chao Zhao; Xiao Shan Feng
Journal:  J Breast Cancer       Date:  2015-06-26       Impact factor: 3.588

5.  Effects of granulocyte-colony stimulating factor and the expression of its receptor on various malignant cells.

Authors:  Hee Won Moon; Tae Young Kim; Bo Ra Oh; Sang Mee Hwang; Jiseok Kwon; Ja-Lok Ku; Dong Soon Lee
Journal:  Korean J Hematol       Date:  2012-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.